Your browser doesn't support javascript.
loading
Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review.
Chiang, Jianbang; Chua, Ziyang; Chan, Jia Ying; Sule, Ashita Ashish; Loke, Wan Hsein; Lum, Elaine; Ong, Marcus Eng Hock; Graves, Nicholas; Ngeow, Joanne.
Afiliación
  • Chiang J; Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore.
  • Chua Z; Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore, 169857, Singapore.
  • Chan JY; Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore.
  • Sule AA; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, 308232, Singapore.
  • Loke WH; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
  • Lum E; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
  • Ong MEH; Health Services & Systems Research, Duke-NUS Medical School, Singapore, 169857, Singapore.
  • Graves N; Health Services & Systems Research, Duke-NUS Medical School, Singapore, 169857, Singapore.
  • Ngeow J; Department of Emergency Medicine, Singapore General Hospital, Singapore, 169608, Singapore.
NPJ Genom Med ; 9(1): 26, 2024 Apr 03.
Article en En | MEDLINE | ID: mdl-38570510
ABSTRACT
Hereditary cancer syndromes constitute approximately 10% of all cancers. Cascade testing involves testing of at-risk relatives to determine if they carry the familial pathogenic variant. Despite growing efforts targeted at improving cascade testing uptake, current literature continues to reflect poor rates of uptake, typically below 30%. This study aims to systematically review current literature on intervention strategies to improve cascade testing, assess the quality of intervention descriptions and evaluate the implementation outcomes of listed interventions. We searched major databases using keywords and subject heading of "cascade testing". Interventions proposed in each study were classified according to the Effective Practice and Organization of Care (EPOC) taxonomy. Quality of intervention description was assessed using the TIDieR checklist, and evaluation of implementation outcomes was performed using Proctor's Implementation Outcomes Framework. Improvements in rates of genetic testing uptake was seen in interventions across the different EPOC taxonomy strategies. The average TIDieR score was 7.3 out of 12. Items least reported include modifications (18.5%), plans to assess fidelity/adherence (7.4%) and actual assessment of fidelity/adherence (7.4%). An average of 2.9 out of 8 aspects of implementation outcomes were examined. The most poorly reported outcomes were cost, fidelity and sustainability, with only 3.7% of studies reporting them. Most interventions have demonstrated success in improving cascade testing uptake. Uptake of cascade testing was highest with delivery arrangement (68%). However, the quality of description of interventions and assessment of implementation outcomes are often suboptimal, hindering their replication and implementation downstream. Therefore, further adoption of standardized guidelines in reporting of interventions and formal assessment of implementation outcomes may help promote translation of these interventions into routine practice.

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: NPJ Genom Med Año: 2024 Tipo del documento: Article País de afiliación: Singapur

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: NPJ Genom Med Año: 2024 Tipo del documento: Article País de afiliación: Singapur